Recent News

• 04.04.2025 - Erika Example Event
• 04.04.2025 - Erika Example Event
• 04.02.2025 - Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025
• 04.02.2025 - Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025
• 03.25.2025 - CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™)
• 03.25.2025 - CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™)
• 03.10.2025 - CervoMed Data Call
• 03.10.2025 - CervoMed Data Call
• 03.10.2025 - CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
• 03.10.2025 - CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies

Recent Filings

• 03.18.2025 - EX-99.1 EX-99.1
• 03.18.2025 - 8-K Current report
• 03.17.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.17.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.11.2025 - 8-K Current report
• 03.10.2025 - 8-K Current report
• 03.10.2025 - EX-99.1 EX-99.1
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities